Novel interaction of antioxidant-1 with TRAF4: role in inflammatory responses in endothelial cells
Authors:
- 25 September 2019
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 317 (6) , C1161-C1171
Abstract
NADPH oxidase (NOX)-derived reactive oxygen species (ROS) and copper (Cu), an essential micronutrient, have been implicated in vascular inflammatory diseases. We reported that in proinflammatory cytokine TNF-α-stimulated endothelial cells (ECs), cytosolic Cu chaperone antioxidant-1 (Atox1) functions as a Cu-dependent transcription factor for the NOX organizer p47phox, thereby increasing ROS-dependent inflammatory gene expression. However, the role and mechanism of Atox1 nuclear translocation in inflamed ECs remain unclear. Using enface staining and nuclear fractionation, here we show that Atox1 was localized in the nucleus in inflamed aortas from ApoE−/− mice with angiotensin II infusion on a high-fat diet, while it was found in cytosol in those from control mice. In cultured human ECs, TNF-α stimulation promoted Atox1 nuclear translocation within 15 min, which was associated with Atox1 binding to TNF-α receptor-associated factor 4 (TRAF4) in a Cu-dependent manner. TRAF4 depletion by siRNA significantly inhibited Atox1 nuclear translocation, p47phox expression, and ROS production as well as its downstream VCAM1/ICAM1 expression and monocyte adhesion to inflamed ECs, which were rescued by overexpression of nuclear targeted Atox1. Furthermore, Atox1 colocalized with TRAF4 at the nucleus in TNF-α-stimulated inflamed ECs and vessels. In summary, Cu-dependent Atox1 binding to TRAF4 plays an important role in Atox1 nuclear translocation and ROS-dependent inflammatory responses in TNF-α-stimulated ECs. Thus the Atox1-TRAF4 axis is a novel therapeutic target for vascular inflammatory disease such as atherosclerosis.Keywords
Funding Information
- HHS | NIH | National Heart, Lung, and Blood Institute (R01 HL070187, R01HL116976, R01HL135584, R01HL133613, R01HL135584)
- American Heart Association (16POST27790038, 15SDG25700406)
- U.S. Department of Veterans Affairs (I01BX001232)
This publication has 42 references indexed in Scilit:
- Structural biology study of human TNF receptor associated factor 4 TRAF domainProtein & Cell, 2013
- TRAF molecules in cell signaling and in human diseasesJournal of Molecular Signaling, 2013
- Conditional Targeting of Tumor Necrosis Factor Receptor–Associated Factor 6 Reveals Opposing Functions of Toll-Like Receptor Signaling in Endothelial and Myeloid Cells in a Mouse Model of AtherosclerosisCirculation, 2012
- Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular SystemCirculation Research, 2012
- Copper chelation by tetrathiomolybdate inhibits lipopolysaccharide-induced inflammatory responses in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- PKCζ mediates disturbed flow-induced endothelial apoptosis via p53 SUMOylationJournal of Cell Biology, 2011
- Tumor Necrosis Factor Receptor–Associated Factor 1 (TRAF1) Deficiency Attenuates Atherosclerosis in Mice by Impairing Monocyte Recruitment to the Vessel WallCirculation, 2010
- Novel mechanism for regulation of extracellular SOD transcription and activity by copper: Role of antioxidant-1Free Radical Biology and Medicine, 2009
- Novel Role of Antioxidant-1 (Atox1) as a Copper-dependent Transcription Factor Involved in Cell ProliferationJournal of Biological Chemistry, 2008
- Inflammation in atherosclerosisNature, 2002